OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges
Lin Kang, Shilin Jin, Jiayi Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 458-473
Open Access | Times Cited: 64

Showing 51-75 of 64 citing articles:

Bioorthogonal chemical engineering of rAAV capsid: Advancing gene therapy targeting using proteins
Maia Marchand, Sébastien Depienne, Mohammed Bouzelha, et al.
(2024)
Open Access | Times Cited: 1

Advancements in ultrasound-mediated drug delivery for central nervous system disorders
Chi-Fen Chuang, Thi-Nhan Phan, Ching‐Hsiang Fan, et al.
Expert Opinion on Drug Delivery (2024), pp. 1-16
Closed Access | Times Cited: 1

Ataxia with giant axonopathy in Acbd5-deficient mice halted by adeno-associated virus gene therapy
Luís Granadeiro, Violeta Enríquez Zarralanga, Ricardo Abreu da Rosa, et al.
Brain (2023) Vol. 147, Iss. 4, pp. 1457-1473
Closed Access | Times Cited: 2

An Induced Pluripotent Stem Cell-Derived Human Blood–Brain Barrier (BBB) Model to Test the Crossing by Adeno-Associated Virus (AAV) Vectors and Antisense Oligonucleotides
Jamuna Selvakumaran, Simona Ursu, Mélissa Bowerman, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2700-2700
Open Access | Times Cited: 1

AAV-mediated gene therapy for Sialidosis
Diantha van de Vlekkert, Huimin Hu, Leigh E. Fremuth, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Characterization and Engineered U1 snRNA Rescue of Splicing Variants in a Turkish Neurodevelopmental Disease Cohort
Ece Sönmezler, Cristiana Stuani, Semra Hız Kurul, et al.
Human Mutation (2024) Vol. 2024, pp. 1-17
Open Access

Characterization of brain transduction capability of a BBB-penetrant, peptide-displaying AAV vector in mice, rats and non-human primates
Rubén Hernández-Alcoceba, María Buñuales, Angeles Garduno, et al.
Research Square (Research Square) (2024)
Open Access

Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2
Jannik T. Wagner, Sandra M. Müller-Schmucker, Wenjun Wang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access

Predicted deleterious variants in the human genome relevant to gene therapy with adeno-associated virus vectors
Mahboubeh Rostami, Philip L. Leopold, Jenifer M Vasquez, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 31, pp. 101136-101136
Open Access

Circuit-specific gene therapy is knocking on the door of Parkinson’s disease
Yueqi Wang, Ming Yin, Zhe-Shan Guo
动物学研究 (2023) Vol. 44, Iss. 6, pp. 1152-1153
Open Access

Previous Page - Page 3

Scroll to top